Weaver Consulting Group’s NeoGenomics NEO Stock Holding History

Weaver Consulting Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-300	Closed	-$11K	–	619
2020 Q3	$11K	Hold	300	–	–	0.01%	543
2020 Q2	$9K	Buy	+300	New	+$8.31K	0.01%	562
2020 Q1	–	Sell	-1,000	Closed	-$19K	–	917
2019 Q4	$19K	Buy	+1,000	New	+$23.8K	0.01%	372

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Weaver Consulting Group's NEO Position: Q4 2020 in Review

Weaver Consulting Group sold out of NeoGenomics (NEO) in Q4 2020, closing a stake of 300 shares — an estimated $11K sold.

Weaver Consulting Group first reported a position in NEO in Q4 2019 and held it in 3 quarters. The position peaked at $19K in Q4 2019. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

Weaver Consulting Group reported no remaining NeoGenomics position as of Q4 2020 after selling out during the quarter.
Weaver Consulting Group sold 300 NeoGenomics shares in Q4 2020, an estimated $11K.
Weaver Consulting Group first reported a position in NeoGenomics in Q4 2019 and held it in 3 quarters.
Weaver Consulting Group's NeoGenomics position peaked at $19K in Q4 2019.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.